Literature DB >> 6358244

Discordant disappearance of bioactive and immunoreactive parathyroid hormone after parathyroidectomy.

D Goltzman, H Gomolin, A DeLean, M Wexler, J L Meakins.   

Abstract

The disappearance of plasma PTH after parathyroidectomy was assessed in patients with primary hyperparathyroidism and normal renal function, chronic renal failure or restored renal function (after transplantation). Plasma PTH levels were determined by renal cytochemical bioassay and by midregion and carboxyl-terminal RIAs. Baseline PTH levels were lower in each patient when assessed by bioassay than when determined by RIA, and the rate of hormone disappearance was faster when determined by bioassay than when measured by RIA. This difference was accentuated in chronic renal failure due to prolongation of the disappearance rates of midregion and carboxyl-terminal immunoreactivity. The half-life of bioassayable hormone in patients with chronic renal failure was prolonged less than 2-fold compared to the half-life in patients with normal or restored renal function. The results emphasize the discordance between levels of bioactive and immunoreactive hormone regardless of renal function, demonstrate that this discordance is augmented after acute reduction in circulating hormone, and show that it is further increased when kidney function is impaired. The studies also implicate extrarenal mechanisms as a major factor in the clearance of bioactive hormone in established renal failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6358244     DOI: 10.1210/jcem-58-1-70

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Comparison of 'intraoperative' parathormone measurement with frozen section during parathyroid surgery.

Authors:  W Madira; G S Robertson; N J London; S J Iqbal; P R Bell; P S Veitch
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

2.  Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy.

Authors:  C Davies; M J Demeure; A St John; A J Edis
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

3.  Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay.

Authors:  Hiroyuki Yamashita; Ping Gao; Shiro Noguchi; Tom Cantor; Shinya Uchino; Shin Watanabe; Hiroto Yamashita; Hitoshi Kawamoto; Masafumi Fukagawa
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

4.  Intact parathyroid hormone levels in renal insufficiency.

Authors:  V T Fajtova; M H Sayegh; N Hickey; P Aliabadi; J M Lazarus; M S LeBoff
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

5.  Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone.

Authors:  S Minisola; L Scarnecchia; E Romagnoli; V Carnevale; M T Pacitti; A Scarda; R Rosso; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 6.  Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery.

Authors:  P Udén; A Chan; Q Y Duh; A Siperstein; O H Clark
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

7.  Establish pre-clinical diagnostic efficacy for parathyroid hormone as a point-of-surgery-testing-device (POST).

Authors:  Ambalika S Tanak; Sriram Muthukumar; Ibrahim A Hashim; Shalini Prasad
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.